# India Drug Infusion System Market

> India Drug Infusion System Market Research Report By Product Type (Elastomeric Infusion System, Disposable Infusion System), By Application (Oncology/Chemotherapy), By Mode of Administration (Intravenous), and By End User (Hospitals) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.32%
- **2024:** $ 493.5 Million
- **2025:** $ 519.75 Million
- **2035:** $ 872.8 Million
- **Key Players:** Baxter International Inc (US), B. Braun Melsungen AG (DE), Medtronic plc (IE), Smiths Medical (US), Fresenius Kabi AG (DE), Terumo Corporation (JP), ICU Medical, Inc. (US), Halyard Health, Inc. (US), Zyno Medical LLC (US)

**Report ID:** MRFR/Pharma/54781-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-drug-infusion-system-market-56547

---

## Market Summary

## **India Drug Infusion System Market Overview**

As per MRFR analysis, the India Drug Infusion System Market size was estimated at 432.5 (USD Million) in 2023. The India Drug Infusion System Market Industry is expected to grow from 454.16 (USD Million) in 2024 to 689.68 (USD Million) by 2035. The India Drug Infusion System Market CAGR (growth rate) is expected to be around 3.871% during the forecast period (2025 - 2035).

### **Key India Drug Infusion System Market Trends Highlighted**

The India Drug Infusion System Market is witnessing significant trends driven by the growing need for advanced healthcare solutions. The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disorders is a crucial market driver, as these conditions often require precise and efficient drug administration. Moreover, the increasing aging population in India is fueling the demand for reliable drug delivery systems, further accelerating growth in this sector.

Opportunities in the market include the adoption of smart infusion systems that enhance accuracy in drug delivery and reduce medication errors. As Indian healthcare facilities look to modernize their infrastructure, the integration of smart technology and connectivity features in infusion systems represents a potential avenue for companies to explore. The government's 'Digital India' initiative, which promotes the integration of technology into healthcare, is consistent with this modernization.

Recent trends suggest a trend toward the development of ambulatory infusion systems that provide patients with portable solutions, thereby allowing them to maintain a higher quality of life while undergoing treatment. In addition, there is an increasing recognition among healthcare professionals of the significance of effectively training and managing infusion devices.

This has resulted in a greater emphasis on educational programs for medical staff. This trend is bolstered by partnerships between healthcare institutions and technology providers, which aim to improve patient safety and user competency. In general, the India Drug Infusion System Market is a dynamic environment that is defined by a commitment to innovation, clever technology, and comprehensive training, all of which are in response to the distinctive healthcare requirements of the population.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **India Drug Infusion System Market Drivers**

### **Increasing Prevalence of Chronic Diseases**

The India Drug Infusion System Market Industry is witnessing significant growth due to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions. According to the National Health Mission, India reported a staggering 8 million new cancer cases in 2020 alone, with cancer-related deaths reaching approximately 7,84,800 individuals that year.

This increasing patient population underscores the need for effective drug delivery systems that provide precise medication administration, highlighting the necessity for advanced drug infusion systems. Organizations like the Indian Cancer Society are actively working to improve cancer patient care standards through modern treatment technologies. Such advancements in drug infusion systems are poised to cater specifically to this rising demand, further propelling market growth in the coming years.

### **Advancements in Medical Technology**

Technological innovations in drug infusion systems have played a pivotal role in the India Drug Infusion System Market Industry expansion. The introduction of smart infusion pumps, which feature dose error-reduction systems and integration with electronic health records, enhances patient safety and medication administration efficiency. A report from the Ministry of Health and Family Welfare highlighted that over 50% of hospitals in urban regions are now adopting advanced medical technologies.

These advancements not only improve treatment outcomes but also attract healthcare providers to invest in superior drug delivery systems, thereby indicating a boost for the market in India.

### **Government Initiatives for Healthcare Infrastructure Development**

The Indian government's commitment to enhancing healthcare infrastructure significantly influences the India Drug Infusion System Market Industry. Initiatives such as the National Health Mission aim to improve healthcare access across regions, especially in rural settings. The Government of India allocated over USD 2 billion for healthcare infrastructure in the last fiscal year, reflecting its emphasis on establishing better medical facilities.

With improved healthcare infrastructure, hospitals and clinics are more likely to invest in advanced drug infusion systems to provide quality care to their patients. This creates a favorable market environment, driving growth for drug infusion systems in India.

## **India Drug Infusion System Market Segment Insights**

### **Drug Infusion System Market Product Type Insights**

The India Drug Infusion System Market shows a multifaceted approach to drug delivery, primarily categorized under Product Type, including notable categories such as Elastomeric Infusion Systems and Disposable Infusion Systems. These segments have become increasingly significant within the industry, addressing the evolving needs of healthcare delivery in India. Elastomeric Infusion Systems are particularly valued for their simplicity and reliability.

They allow for consistent medication delivery while minimizing patient and caregiver burden. They are designed for various applications in clinical settings, making them ideal for long-term infusions and chronic treatments, which are increasingly common in Indian healthcare. On the other hand, Disposable Infusion Systems have gained traction due to their cost-effectiveness and enhanced safety features.

The increasing prevalence of hospital-acquired infections has prompted a shift towards disposable technologies, as they eliminate risks associated with reusable devices. With healthcare facilities striving to adhere to strict hygiene protocols, the demand for Disposable Infusion Systems has surged. Furthermore, government initiatives in India aimed at improving healthcare infrastructure have facilitated greater accessibility to these advanced drug delivery technologies, thereby enhancing patient care and treatment outcomes.

The emphasis on minimizing the risks associated with infection and ensuring accurate dosing has driven innovations in both segments. In a bid to modernize its healthcare landscape, India is viewing these technologies not just as options but as essential components of effective medical treatment. As the healthcare system continues to evolve with a focus on patient-centered approaches and efficient service delivery, the significance of the Elastomeric and Disposable Infusion Systems is expected to grow further, revealing ample opportunities for advancement and expansion in the India Drug Infusion System Market.

The overarching health policies undertaken by the Indian government aim to reduce healthcare costs while enhancing the quality of care, highlighting the critical role these systems play in the future of medical treatments in India.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Drug Infusion System Market Application Insights**

The Application segment of the India [Drug Infusion System Market](../../../reports/drug-infusion-system-market-6207) plays a critical role in the delivery of medications across various healthcare settings. Notably, Oncology and Chemotherapy stand out as vital areas where drug infusion systems are extensively utilized, primarily due to the increasing prevalence of cancer and the need for precise treatment methodologies.

As the demand for effective cancer treatment rises, the integration of advanced drug infusion systems is becoming essential for managing complex chemotherapy regimens. This significant reliance on drug infusion technology is driven by the growing focus on patient-centric care and improved therapeutic outcomes in oncology. Furthermore, the Indian government has been actively promoting initiatives to enhance oncology services and medical facilities, which bolsters the value of this segment.

The integration of innovative technologies aims to increase the efficiency of drug delivery, ensuring that patients receive optimal dosages safely and effectively. Overall, the Oncology and Chemotherapy application area is positioned to dominate the India Drug Infusion System Market, reflecting the critical importance of addressing the challenges associated with cancer treatment delivery in the nation.

### **Drug Infusion System Market Mode of Administration Insights**

The India Drug Infusion System Market is segmented by Mode of Administration, with a strong focus on Intravenous methods, which play a critical role in healthcare delivery. Intravenous administration is preferred due to its direct and rapid effects, making it vital in emergency and critical care settings. This method allows for precise control over drug delivery rates, enhancing therapeutic efficacy.

Additionally, the rising prevalence of chronic diseases, along with a growing elderly population in India, is driving the demand for intravenous infusion systems. Furthermore, advancements in technology and the introduction of smart infusion pumps are expected to improve patient outcomes and efficiency. However, challenges such as the risk of complications from intravenous access can impact the growth of this segment.

Overall, the Intravenous segment represents a significant portion of the India Drug Infusion System Market, reflecting trends in healthcare practices and technological innovations that prioritize patient safety and effective treatment delivery.

### **Drug Infusion System Market End User Insights**

The End User segment of the India Drug Infusion System Market is significantly influenced by the demand from hospitals, which are crucial settings for drug administration. Hospitals utilize drug infusion systems for a variety of treatments, including anesthesia and chemotherapy, thus making their efficiency and reliability vital for patient care. As India's healthcare infrastructure evolves, hospitals are increasingly adopting advanced infusion systems that improve patient monitoring and medication safety.

This trend is driven by the growing prevalence of chronic diseases that require long-term treatments, combined with government initiatives aimed at enhancing healthcare services across the country. The increasing number of hospital admissions and outpatient treatments further underscores the importance of infusion systems in hospital protocols, driving innovations and upgrades in this segment. With a focus on patient-centric initiatives, there is considerable emphasis on integrating smart infusion technologies that facilitate better management of drug dosages and empower healthcare professionals to enhance delivery outcomes.

This positioning highlights hospitals as a dominant sector within the India Drug Infusion System Market, underscoring their critical role in shaping the overall landscape of drug delivery systems in the region.

## **India Drug Infusion System Market Key Players and Competitive Insights**

The India Drug Infusion System Market has been experiencing significant evolution and growth driven by increasing healthcare needs, technological advancements, and rising incidences of chronic diseases that require sophisticated treatment approaches. As hospitals and healthcare facilities in India continue to expand and invest in advanced medical technologies, the demand for reliable drug infusion systems is expected to grow.

This market is characterized by several players ranging from established multinational corporations to local manufacturers, all striving to capture a significant share of the market by offering innovative solutions that enhance patient care and streamline the drug administration process. Competition in this sector is intensified by the frequent introduction of new products and technologies designed to improve efficiency and safety in drug delivery, along with regulatory requirements that necessitate high standards of quality and reliability.

Hospira has established a strong presence in the India Drug Infusion System Market, leveraging its expertise in medication delivery and infusion technology. The company's robust portfolio includes a variety of infusion pumps and delivery systems that are designed to meet the increasing complexities of drug administration in clinical settings. With a focus on quality and safety, Hospira emphasizes the reliability of its infusion devices, which cater to both critical care and general patient care environments.

The strengths of Hospira also lie in its supply chain efficiency and strategic partnerships that enhance its distribution capabilities across India, ensuring that healthcare providers have easy access to its innovative solutions. Furthermore, its commitment to continuous improvement and responsiveness to market needs aids in maintaining a competitive edge in the dynamic Indian healthcare landscape.

ICU Medical is another prominent player in the India Drug Infusion System Market, well-regarded for its advanced infusion systems and component parts that prioritize patient safety and caregiver efficiency. The company's offerings include a variety of infusion pumps that integrate cutting-edge technology and user-friendly interfaces, which are particularly advantageous in busy clinical environments. ICU Medical's market presence is bolstered by its strong emphasis on quality control and its commitment to regulatory compliance, making its products a common choice among healthcare providers in India.

The company's focus on strategic mergers and acquisitions has further enhanced its capabilities and technology portfolio, allowing it to continually innovate and adapt its service offerings to better meet the needs of the Indian market. This ongoing investment in research and development underscores ICU Medical's commitment to delivering exceptional infusion solutions that align with the evolving demands of the healthcare sector in India.

### **Key Companies in the India Drug Infusion System Market Include**

- Hospira
- ICU Medical
- [Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products/neurological/drug-infusion-systems.html#aq=%40pagetype%3D%22product-model%22&cq=%40products_group%3D%22Drug%20infusion%20systems%22%20OR%20%40ontology_isa%3D%22Drug%20infusion%20systems%22)
- Fresenius Kabi
- Nipro Corporation
- 3M
- Parker Hannifin
- Smiths Medical
- Terumo Corporation
- Halyard Health
- Baxter International
- Johnson & Johnson
- Sysmex Corporation
- Cook Medical
- B. Braun Melsungen AG

### **India Drug Infusion System Market Industry Developments**

The India Drug Infusion System Market has witnessed notable developments recently, particularly with increasing demand for advanced healthcare solutions. Fresenius Kabi expanded its portfolio significantly in September 2023 with the launch of new infusion devices tailored to improve patient safety and drug delivery efficiency. In August 2023, ICU Medical announced an uptick in revenue influenced by rising healthcare expenditures in India, indicating strong market potential.

Mergers and acquisitions have also been a theme, as in July 2023, Medtronic completed its acquisition of a regional player to enhance its infusion systems offerings. Market valuations are growing, with companies like Baxter International and Terumo Corporation investing in local manufacturing capabilities, resulting in improved accessibility and affordability of infusion devices across the nation.

Over the past 2-3 years, the market has seen substantial growth due to technological advancements, with hospitals increasingly opting for smart infusion systems. In November 2022, Johnson and Johnson unveiled an innovative drug imaging solution, which further solidified its presence in the Indian healthcare sector. With ongoing government initiatives to improve healthcare infrastructure, the Drug Infusion System Market in India is poised for sustained growth and modernization.

## **India Drug Infusion System Market Segmentation Insights**

### **Drug Infusion System Market Product Type Outlook**

- Elastomeric Infusion System
- Disposable Infusion System

### **Drug Infusion System Market Application Outlook**

- Oncology/Chemotherapy

### **Drug Infusion System Market Mode of Administration Outlook**

- Intravenous

### **Drug Infusion System Market End User Outlook**

- Hospitals

## Market Drivers

### Growing Awareness of Patient Safety

There is a heightened awareness of patient safety and the importance of accurate drug delivery in India, which is influencing the drug infusion-system market. Healthcare professionals and institutions are increasingly recognizing the risks associated with manual drug administration, leading to a shift towards automated infusion systems. This trend is supported by various initiatives aimed at improving patient outcomes and reducing medication errors. The market for drug infusion systems is projected to grow by approximately 10% annually as hospitals and clinics adopt these technologies to enhance patient safety. The emphasis on safety and precision in drug delivery is likely to drive innovation within the drug infusion-system market, fostering the development of more sophisticated and reliable systems.

### Expansion of Home Healthcare Services

The expansion of home healthcare services in India is likely to create new opportunities. This will benefit the drug infusion-system market. As more patients prefer receiving care at home, the demand for portable and user-friendly drug infusion systems is increasing. This trend is supported by the growing aging population and the rising incidence of chronic illnesses, which necessitate ongoing treatment. The home healthcare market is projected to grow at a rate of 20% annually, indicating a substantial opportunity for drug infusion systems designed for home use. This shift towards home-based care may significantly impact the drug infusion-system market, as it adapts to meet the needs of patients seeking convenient and effective treatment options.

### Technological Integration in Healthcare

The integration of advanced technologies, such as IoT and AI, into healthcare practices is transforming the drug infusion-system market in India. These technologies enable real-time monitoring and data analysis, which can enhance the efficiency and effectiveness of drug delivery systems. Hospitals are increasingly adopting smart infusion pumps that can communicate with electronic health records, allowing for better tracking of medication administration. This technological shift is expected to propel the drug infusion-system market, with a projected growth rate of 14% over the next few years. The potential for improved patient outcomes and operational efficiency positions the drug infusion-system market as a key player in the evolving healthcare landscape.

### Rising Demand for Chronic Disease Management

The increasing prevalence of chronic diseases in India, such as diabetes and cardiovascular disorders, drives the demand for effective treatment solutions. The drug infusion-system market is likely to benefit from this trend, as healthcare providers seek advanced methods to manage these conditions. According to recent estimates, chronic diseases account for approximately 60% of all deaths in India, highlighting the urgent need for efficient drug delivery systems. As healthcare facilities expand and improve, the adoption of drug infusion systems is expected to rise, potentially leading to a market growth rate of around 15% annually. This growing demand for chronic disease management solutions positions the drug infusion-system market as a critical component of India's healthcare landscape.

### Increased Investment in Healthcare Infrastructure

India's government and private sector are significantly investing in healthcare infrastructure, which is likely to enhance the drug infusion-system market. The National Health Mission aims to improve healthcare access and quality, with a budget allocation of over $10 billion for various health initiatives. This investment is expected to facilitate the establishment of more hospitals and clinics equipped with modern medical technologies, including drug infusion systems. As healthcare facilities upgrade their equipment, the demand for advanced drug delivery systems is anticipated to rise. This trend may lead to a more robust drug infusion-system market, with an expected growth rate of 12% over the next few years, reflecting the increasing focus on quality healthcare delivery.

## Future Outlook

The [Drug Infusion System Market](https://www.marketresearchfuture.com/reports/drug-infusion-system-market-6207) in India is projected to grow at a 5.32% CAGR from 2025 to 2035. This growth is driven by technological advancements and increasing healthcare demands.

**New opportunities:**

- Development of smart infusion pumps with IoT integration
- Expansion of home healthcare infusion services
- Partnerships with telehealth platforms for remote monitoring solutions

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs.

## Segment Insights

### By Product Type: Elastomeric infusion system (Largest) vs. Syringe infusion system (Fastest-Growing)

In the India drug infusion-system market, the market share distribution among different product types showcases a competitive landscape. The elastomeric infusion system holds a significant share, asserting its dominance in both hospitals and home care settings. In contrast, the syringe infusion system, while smaller in market share compared to elastomeric systems, is rapidly gaining traction due to its ease of use and versatility across various medical contexts.

Growth trends within the product type segment reflect increasing patient-centric approaches and technological advancements. The syringe infusion system is witnessing the fastest growth in response to the rising demand for outpatient care services. Furthermore, advancements in design, safety features, and integration with digital health solutions are driving adoption rates across several product types, enhancing overall market competitiveness.

Elastomeric infusion system (Dominant) vs. Syringe infusion system (Emerging)

The elastomeric infusion system stands as the dominant product in the India drug infusion-system market, characterized by its self-contained features, ease of operation, and reliability for prolonged drug delivery. It is particularly favored in scenarios requiring extended therapy, offering benefits like reduced infection risk due to no need for continuous IV access. On the other hand, the syringe infusion system is emerging rapidly, appealing to healthcare providers for its compact design and flexibility in administering a variety of medications. With advancements that improve syringe precision and minimize errors, its popularity is surging, particularly in outpatient facilities. Both systems play vital roles, yet their distinct properties cater to diverse patient and clinical needs.

### By Application: Oncology/Chemotherapy (Largest) vs. Diabetes (Fastest-Growing)

The market for drug infusion systems in the India drug infusion-system market exhibits a diverse distribution across various application segments. Oncology and chemotherapy are currently the largest segments, driven by the rising prevalence of cancer and the increasing adoption of advanced treatment options. Other significant segments include diabetes and analgesia, which also contribute notably to the overall market share, while pediatrics and nutrition hold smaller portions yet remain crucial for comprehensive patient care.

Growth trends indicate that the diabetes segment is the fastest-growing due to the surge in diabetes cases linked to lifestyle changes, emphasizing the need for effective drug infusion solutions. Additionally, advancements in technology and increased focus on home care settings are further propelling the demand for these systems across the applications. The integration of smart technologies in infusion systems is also set to enhance treatment efficiency and patient monitoring, leading to expansive growth in this sector.

Oncology/Chemotherapy (Dominant) vs. Diabetes (Emerging)

Oncology and chemotherapy represent the dominant application in the India drug infusion-system market, primarily due to the increasing incidence of cancer and the evolving landscape of oncology treatments that require sophisticated drug delivery methods. These treatments necessitate precise dosing and monitoring, which drug infusion systems are well-equipped to provide. In contrast, the diabetes segment is emerging, driven by the alarming rise in diabetes prevalence and the need for effective management strategies. Innovations in infusion technology catering to diabetic patients, such as insulin pumps, are on the rise. Both segments underline a shift towards personalized and technology-driven healthcare solutions in the region, highlighting the importance of tailored approaches to meet the specific needs of patients.

### By Mode of administration: Intravenous (Largest) vs. Subcutaneous (Fastest-Growing)

Among the modes of administration in the India drug infusion-system market, intravenous (IV) stands out as the dominant approach, holding the largest market share. Subcutaneous administration, however, is rapidly gaining traction, positioned as the fastest-growing segment within this market. The increasing prevalence of chronic diseases and the need for continuous medication delivery are driving this distribution, with healthcare providers increasingly favoring IV systems for their efficiency in acute care settings.

The growth trends in this segment are influenced by advancements in technology and increasing patient preferences for less invasive options. The rise in outpatient care and home healthcare services further supports the shift towards subcutaneous methods, making them particularly appealing for long-term therapies. As patient awareness and acceptance grow, manufacturers are introduced innovative solutions that enhance comfort and convenience, propelling the segment's expansion.

Intravenous (Dominant) vs. Subcutaneous (Emerging)

The intravenous (IV) segment remains dominant in the India drug infusion-system market due to its ability to facilitate rapid drug delivery and is essential for emergency care scenarios. IV systems are critical for administering antibiotics, chemotherapy, and hydration therapies, making them indispensable in hospital settings. On the other hand, the subcutaneous segment is viewed as an emerging player, primarily driven by the increasing demand for self-administered medications and the convenience they offer. Subcutaneous methods are particularly favored for their simplicity and ease of use, suitable for chronic conditions where long-term treatment is necessary. As these systems evolve, we can expect advancements in device technology that further enhance patient compliance and their integration into diverse healthcare settings.

### By End-user: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the India drug infusion-system market, hospitals hold the largest market share, attributed to their extensive infrastructure and constant demand for advanced healthcare solutions. Ambulatory surgical centers, while smaller in share, are rapidly gaining ground due to the rise in outpatient procedures and a shift towards more cost-effective healthcare delivery models. Diagnostic centers are also playing a significant role, though their market position is more niche compared to hospitals and surgical centers.

The growth trends within this segment are largely driven by an increased focus on patient-centric care and technological advancements in drug infusion systems. Hospitals are investing in innovative infusion technologies to improve patient outcomes and streamline operations. On the other hand, ambulatory surgical centers are emerging as a preferred choice for many patients seeking efficiency and convenience, contributing to their rapid growth in the market, supported by favorable regulations and reimbursement policies.

Hospitals: Dominant vs. Ambulatory Surgical Centers: Emerging

Hospitals are the dominant players in the end-user segment, characterized by large-scale operations and a wide array of services offered, which include complex surgeries and critical care. They typically require advanced drug infusion systems to support a variety of procedures, leading to significant procurement volumes. Meanwhile, ambulatory surgical centers are categorized as emerging entities within this market. These facilities emphasize outpatient procedures and are half the size of traditional hospitals, representing a shift towards more efficient care models. Their growing presence is fueled by increasing patient preferences for minimally invasive procedures and cost efficiencies. As these centers enhance their operational capabilities, they continue to capture a larger share of the market, positioning themselves as key facilitators of modern healthcare.

## Competitive Benchmarking

The drug infusion-system market in India is characterized by a dynamic competitive landscape, driven by increasing healthcare demands and technological advancements. Major players such as Baxter International Inc (US), B. Braun Melsungen AG (DE), and Medtronic plc (IE) are strategically positioned to leverage innovation and regional expansion. Baxter International Inc (US) focuses on enhancing its product portfolio through continuous innovation, while B. Braun Melsungen AG (DE) emphasizes partnerships with local healthcare providers to strengthen its market presence. Medtronic plc (IE) is actively pursuing digital transformation initiatives, which collectively shape a competitive environment that is increasingly reliant on technological integration and customer-centric solutions.Key business tactics within this market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The competitive structure appears moderately fragmented, with several key players exerting influence over market dynamics. This fragmentation allows for a diverse range of products and services, catering to varying customer needs while fostering healthy competition among established and emerging companies.

In October  Baxter International Inc (US) announced a strategic partnership with a leading Indian healthcare provider to co-develop advanced infusion systems tailored for local market needs. This collaboration is expected to enhance Baxter's market penetration and align its offerings with the specific requirements of Indian healthcare facilities, thereby reinforcing its competitive edge in the region.

In September  B. Braun Melsungen AG (DE) launched a new line of smart infusion pumps designed to improve medication safety and patient outcomes. This product introduction not only showcases B. Braun's commitment to innovation but also positions the company as a leader in the integration of technology within infusion systems, potentially attracting a broader customer base.

In August  Medtronic plc (IE) expanded its manufacturing capabilities in India, investing approximately $50 million to enhance production efficiency and meet growing demand. This investment underscores Medtronic's long-term commitment to the Indian market and its strategy to localize production, which may lead to reduced costs and improved supply chain reliability.

As of November  current competitive trends in the drug infusion-system market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances among key players are shaping the landscape, fostering innovation and enhancing product offerings. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to innovate and adapt to evolving market demands.

## Recent News & Developments

The India Drug Infusion System Market has witnessed notable developments recently, particularly with increasing demand for advanced healthcare solutions. Fresenius Kabi expanded its portfolio significantly in September 2023 with the launch of new infusion devices tailored to improve patient safety and drug delivery efficiency. In August 2023, ICU Medical announced an uptick in revenue influenced by rising healthcare expenditures in India, indicating strong market potential.

Mergers and acquisitions have also been a theme, as in July 2023, Medtronic completed its acquisition of a regional player to enhance its infusion systems offerings. Market valuations are growing, with companies like Baxter International and Terumo Corporation investing in local manufacturing capabilities, resulting in improved accessibility and affordability of infusion devices across the nation.

Over the past 2-3 years, the market has seen substantial growth due to technological advancements, with hospitals increasingly opting for smart infusion systems. In November 2022, Johnson and Johnson unveiled an innovative drug imaging solution, which further solidified its presence in the Indian healthcare sector. With ongoing government initiatives to improve healthcare infrastructure, the Drug Infusion System Market in India is poised for sustained growth and modernization.

## Report Scope

| MARKET SIZE 2024 | 493.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 519.75(USD Million) |
| MARKET SIZE 2035 | 872.8(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.32% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Baxter International Inc (US), B. Braun Melsungen AG (DE), Medtronic plc (IE), Smiths Medical (US), Fresenius Kabi AG (DE), Terumo Corporation (JP), ICU Medical, Inc. (US), Halyard Health, Inc. (US), Zyno Medical LLC (US) |
| Segments Covered | Product Type, Application, Mode of administration, End-user |
| Key Market Opportunities | Integration of smart technology in drug infusion systems enhances patient safety and operational efficiency. |
| Key Market Dynamics | Rising demand for advanced drug infusion systems driven by regulatory changes and technological innovations in healthcare. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What is the current valuation of the India drug infusion-system market?**
A: The market valuation was $493.5 Million in 2024.

**Q: What is the projected market size for the India drug infusion-system market by 2035?**
A: The market is expected to reach $872.8 Million by 2035.

**Q: What is the expected CAGR for the India drug infusion-system market during the forecast period 2025 - 2035?**
A: The expected CAGR is 5.32% during the forecast period.

**Q: Which product type segment had the highest valuation in 2024?**
A: The disposable infusion system segment had the highest valuation at $98.7 Million in 2024.

**Q: What are the key applications driving the India drug infusion-system market?**
A: Key applications include oncology/chemotherapy, diabetes, analgesia, and nutrition.

**Q: Which end-user segment is projected to dominate the market by 2035?**
A: The hospitals segment is projected to dominate, with a valuation of $200.0 - $350.0 Million.

**Q: Who are the leading players in the India drug infusion-system market?**
A: Key players include Baxter International Inc, B. Braun Melsungen AG, and Medtronic plc.

**Q: What is the valuation range for the intravenous mode of administration in 2024?**
A: The intravenous mode of administration had a valuation range of $200.0 - $350.0 Million in 2024.

**Q: How does the insulin pump segment perform in terms of valuation?**
A: The insulin pump segment had a valuation of $49.35 Million in 2024, with potential growth.

**Q: What is the expected growth trend for the disposable infusion system segment by 2035?**
A: The disposable infusion system segment is likely to grow from $98.7 Million in 2024 to a higher valuation by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-drug-infusion-system-market-56547*